• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

模拟在美国寻找 LGBTQ 特定阿片类药物使用障碍治疗的体验。

Simulating the experience of searching for LGBTQ-specific opioid use disorder treatment in the United States.

机构信息

Columbia University Irving Medical Center, Department of Psychiatry, Division on Substance Use Disorders and New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10030, United States of America.

Teachers College, Columbia University, Department of Counseling & Clinical Psychology, 525 W. 120th Street, New York, NY 10027, United States of America.

出版信息

J Subst Abuse Treat. 2022 Sep;140:108828. doi: 10.1016/j.jsat.2022.108828. Epub 2022 Jun 16.

DOI:10.1016/j.jsat.2022.108828
PMID:35749919
Abstract

INTRODUCTION

Lesbian, gay, bisexual, transgender, and queer (LGBTQ) populations experience opioid-related disparities compared to heterosexual and cisgender populations. LGBTQ-specific services are needed within opioid use disorder (OUD) treatment settings to minimize treatment barriers; research on the availability and accessibility of such services is limited. The purpose of the current study was to mimic the experience of an LGBTQ-identified individual searching for LGBTQ-specific OUD treatment services, using the SAMHSA National Directory of Drug and Alcohol Abuse Treatment Facilities - 2018 (Treatment Directory).

METHODS

We contacted treatment facilities listed in the Treatment Directory as providing both medications for OUD (MOUD) and "special programs/groups" for LGBTQ clients within states with the top 20 highest national opioid overdose rates. We used descriptive statistics to characterize the outcome of calls; and the overall number of facilities offering LGBTQ-specific services, MOUD, and both LGBTQ-specific services and MOUD in each state by 100,000 state population and in relation to opioid overdose mortality rates (programs-per-death rate).

RESULTS

Of the N = 570 treatment facilities contacted, n = 446 (78.25 %) were reached and answered our questions. Of n = 446 reached (all of which advertised both MOUD and LGBTQ-specific services), n = 366 (82.06 %) reported offering MOUD, n = 125 (28.03 %) reported offering special programs or groups for LGBTQ clients, and n = 107 (23.99 %) reported offering both MOUD and LGBTQ-specific services. Apart from Washington, DC, New Mexico, South Carolina, and West Virginia, which did not have any facilities that reported offering both MOUD and LGBTQ-specific services, Illinois had the lowest, and Michigan had the highest programs-per-death rate. Most of the northeastern states on our list (all but New Hampshire) clustered in the top two quarters of programs-per-death rates, while most of southeastern states (all but North Carolina) clustered in the bottom two quarters of programs-per-death rates.

CONCLUSIONS

The lack of LGBTQ-specific OUD treatment services may lead to missed opportunities for supporting LGBTQ people most in need of treatment; such treatment is especially crucial to prevent overdose mortality and improve the health of LGBTQ populations across the United States, particularly in the southeast.

摘要

引言

与异性恋和顺性别群体相比,女同性恋、男同性恋、双性恋、跨性别和酷儿(LGBTQ)群体在阿片类药物相关问题上存在差异。在阿片类药物使用障碍(OUD)治疗环境中需要提供专门针对 LGBTQ 的服务,以最大程度减少治疗障碍;但是,关于此类服务的可及性和可及性的研究有限。本研究的目的是使用 SAMHSA 国家药物和酒精滥用治疗设施目录-2018(治疗目录)模拟一名 LGBTQ 认同者寻找专门针对 LGBTQ 的 OUD 治疗服务的体验。

方法

我们联系了治疗目录中列出的治疗设施,这些治疗设施在国家药物和酒精滥用治疗设施目录-2018(治疗目录)中声称提供阿片类药物使用障碍(OUD)的药物治疗(MOUD)和 LGBTQ 客户的“特殊计划/团体”,这些治疗设施所在的州的全国阿片类药物过量死亡率最高。我们使用描述性统计来描述呼叫结果;并根据州人口每 10 万人和与阿片类药物过量死亡率相关的每个州提供 LGBTQ 特定服务、MOUD 以及 LGBTQ 特定服务和 MOUD 的设施总数,按州列出每个州提供 LGBTQ 特定服务的设施数量、MOUD 和两者的数量。

结果

在联系的 N = 570 个治疗设施中,n = 446(78.25%)被联系到并回答了我们的问题。在 n = 446 个联系到的治疗设施中(均声称提供 MOUD 和 LGBTQ 特定服务),n = 366(82.06%)报告提供 MOUD,n = 125(28.03%)报告提供 LGBTQ 客户的特殊计划或团体,n = 107(23.99%)报告提供 MOUD 和 LGBTQ 特定服务。除了没有任何报告提供 MOUD 和 LGBTQ 特定服务的华盛顿特区、新墨西哥州、南卡罗来纳州和西弗吉尼亚州之外,伊利诺伊州的设施数量最少,密歇根州的死亡率最高。我们名单上的大多数东北部州(除了新罕布什尔州)都集中在前两个季度的死亡率中,而东南部的大多数州(除了北卡罗来纳州)都集中在后两个季度的死亡率中。

结论

缺乏专门针对 LGBTQ 的 OUD 治疗服务可能会导致错失为最需要治疗的 LGBTQ 人群提供支持的机会;这种治疗对于预防阿片类药物过量死亡和改善美国 LGBTQ 人群的健康尤其重要,特别是在东南部。

相似文献

1
Simulating the experience of searching for LGBTQ-specific opioid use disorder treatment in the United States.模拟在美国寻找 LGBTQ 特定阿片类药物使用障碍治疗的体验。
J Subst Abuse Treat. 2022 Sep;140:108828. doi: 10.1016/j.jsat.2022.108828. Epub 2022 Jun 16.
2
The State of the Research on Opioid Outcomes Among Lesbian, Gay, Bisexual, Transgender, Queer, and Other Sexuality- and Gender-Diverse Populations: A Scoping Review.性少数群体(包括女同性恋、男同性恋、双性恋、跨性别、酷儿等)和性别多样化人群中阿片类药物结局的研究现状:范围综述。
LGBT Health. 2023 Jan;10(1):1-17. doi: 10.1089/lgbt.2022.0036. Epub 2022 Oct 31.
3
Utilization of Medications for Opioid Use Disorder Across US States: Relationship to Treatment Availability and Overdose Mortality.美国各州阿片类药物使用障碍药物的使用情况:与治疗可用性和过量死亡率的关系。
J Addict Med. 2022;16(1):114-117. doi: 10.1097/ADM.0000000000000820.
4
Association of Receipt of Opioid Use Disorder-Related Telehealth Services and Medications for Opioid Use Disorder With Fatal Drug Overdoses Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.医疗保险受益人与新冠疫情大流行之前和期间阿片类药物使用障碍相关远程医疗服务和阿片类药物使用障碍药物治疗与致命药物过量的关联。
JAMA Psychiatry. 2023 May 1;80(5):508-514. doi: 10.1001/jamapsychiatry.2023.0310.
5
Barriers and facilitators to use of buprenorphine in state-licensed specialty substance use treatment programs: A survey of program leadership.州许可的专业物质使用治疗计划中使用丁丙诺啡的障碍和促进因素:对项目领导层的调查。
J Subst Use Addict Treat. 2024 Jul;162:209351. doi: 10.1016/j.josat.2024.209351. Epub 2024 Mar 17.
6
Duration of medication treatment for opioid-use disorder and risk of overdose among Medicaid enrollees in 11 states: a retrospective cohort study.11 个州医疗补助受助人中阿片类药物使用障碍药物治疗持续时间与过量用药风险的关系:一项回顾性队列研究。
Addiction. 2022 Dec;117(12):3079-3088. doi: 10.1111/add.15959. Epub 2022 Jun 13.
7
Are North Carolina clinicians delivering opioid use disorder treatment to Medicaid beneficiaries?北卡罗来纳州的临床医生是否为医疗补助受益人群提供阿片类药物使用障碍治疗?
Addiction. 2022 Nov;117(11):2855-2863. doi: 10.1111/add.15854. Epub 2022 Mar 7.
8
Predictors of availability of long-acting medication for opioid use disorder.阿片类药物使用障碍长效药物供应的预测因素。
Drug Alcohol Depend. 2019 Nov 1;204:107586. doi: 10.1016/j.drugalcdep.2019.107586. Epub 2019 Sep 25.
9
Association between treatment setting and outcomes among oregon medicaid patients with opioid use disorder: a retrospective cohort study.俄勒冈州医疗补助计划中患有阿片类药物使用障碍患者的治疗环境与结局之间的关联:一项回顾性队列研究。
Addict Sci Clin Pract. 2022 Aug 19;17(1):45. doi: 10.1186/s13722-022-00318-1.
10
Experiences of and recommendations for LGBTQ+-affirming substance use services: an exploratory qualitative descriptive study with LGBTQ+ people who use opioids and other drugs.支持 LGBTQ+ 的物质使用服务的经验和建议:一项探索性定性描述研究,对象为使用阿片类药物和其他药物的 LGBTQ+ 人群。
Subst Abuse Treat Prev Policy. 2024 Jan 3;19(1):2. doi: 10.1186/s13011-023-00581-8.

引用本文的文献

1
Content analysis of substance use disorder recovery discourse on Twitter: From personal recovery narratives to marketing of addiction treatment.推特上物质使用障碍康复话语的内容分析:从个人康复叙事到成瘾治疗营销
Alcohol Clin Exp Res (Hoboken). 2025 Mar;49(3):629-640. doi: 10.1111/acer.15531. Epub 2025 Feb 22.
2
Patient and provider experiences with opioid use disorder care delivered via telehealth: A systematic mixed-studies review.患者和提供者通过远程医疗接受阿片类物质使用障碍护理的体验:一项系统的混合研究综述。
Drug Alcohol Depend. 2025 Jan 1;266:112522. doi: 10.1016/j.drugalcdep.2024.112522. Epub 2024 Dec 4.
3
Reaching people who use drugs with sexual and reproductive healthcare through syringe services programs: potential promise and missed opportunities.
通过注射服务项目为性健康和生殖健康服务的吸毒者提供服务:潜在的希望和错失的机会。
Harm Reduct J. 2024 Nov 14;21(1):198. doi: 10.1186/s12954-024-01116-5.
4
Strategies to Improve Patient-Centered Care for Drug Use-Associated Infective Endocarditis: JACC Focus Seminar 2/4.改善药物相关感染性心内膜炎患者为中心的护理的策略:JACC 焦点研讨会 2/4。
J Am Coll Cardiol. 2024 Apr 9;83(14):1338-1347. doi: 10.1016/j.jacc.2024.01.034.
5
Experiences of and recommendations for LGBTQ+-affirming substance use services: an exploratory qualitative descriptive study with LGBTQ+ people who use opioids and other drugs.支持 LGBTQ+ 的物质使用服务的经验和建议:一项探索性定性描述研究,对象为使用阿片类药物和其他药物的 LGBTQ+ 人群。
Subst Abuse Treat Prev Policy. 2024 Jan 3;19(1):2. doi: 10.1186/s13011-023-00581-8.
6
Rural and urban differences in disparities in substance use and substance use disorders affecting sexual minority populations.城乡差异对性少数群体物质使用和物质使用障碍的影响。
J Rural Health. 2024 Jun;40(3):542-556. doi: 10.1111/jrh.12816. Epub 2023 Dec 19.
7
Identifying and Treating Incarcerated Women Experiencing Substance Use Disorders: A Review.识别和治疗患有物质使用障碍的被监禁女性:一项综述。
Subst Abuse Rehabil. 2023 Nov 13;14:131-145. doi: 10.2147/SAR.S409944. eCollection 2023.
8
Postmortem toxicology findings from the Camden Opioid Research Initiative.卡姆登阿片类药物研究计划的尸检毒理学研究结果。
PLoS One. 2023 Nov 1;18(11):e0292674. doi: 10.1371/journal.pone.0292674. eCollection 2023.
9
Experiences of and recommendations for LGBTQ+-affirming substance use services: A qualitative study with LGBTQ+ people who use opioids and other drugs.为LGBTQ+群体提供肯定性药物使用服务的经验与建议:一项针对使用阿片类药物及其他毒品的LGBTQ+群体的定性研究。
Res Sq. 2023 Sep 1:rs.3.rs-3303699. doi: 10.21203/rs.3.rs-3303699/v1.
10
Characteristics of Outpatient and Residential Substance Use Disorder Treatment Facilities with a Tailored LGBT Program.设有针对性的 LGBT 项目的门诊和住院物质使用障碍治疗机构的特征。
Subst Abuse. 2023 Jun 16;17:11782218231181274. doi: 10.1177/11782218231181274. eCollection 2023.